Greater China

CMS Healthcare is Norvia’s business partner in Greater China, for distribution of Norvia’s products.

CMS is well-established diversified specialty pharma, with 20-years of successful track record in market execution.

Focused on commercial development in Greater China and Asia.

Publicly traded at Hong Kong Stock Exchange, with a multiple $bn market cap.

CMS have their offices in London, Zurich, Dublin, Malaysia, Dubai, HK and PRC with Operational licenses from SwissMedic and IE HPRA (WDA). Partnering globally.

CMS have a strong foothold both within Ecommerce and pharmacy distribution.

CMS & Norvia believe there is a high need and potential for Norvia’s products in Greater China.